Drugs.com - FDA MedWatch Alerts

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL (10mg/mL) Bags

Audience: Healthcare Provider, Pharmacy, Consumer London, July 22, 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA, Inc. is extending its voluntary recall of one lot (listed below)...

Feb 9, 2025 - 21:45
 0
Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL (10mg/mL) Bags
Audience: Healthcare Provider, Pharmacy, Consumer London, July 22, 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA, Inc. is extending its voluntary recall of one lot (listed below)...
Read More

Tags:

Previous Article

Main Products, Inc. Issues Recall of Umary Acido Hialuronico, Suplemento Aliment...

Next Article

Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Recall of One Lot of ...

Related Posts

Boulla LLC Issues Voluntary Nationwide Recall of Boom Max Capsules Due to the Potential Presence of Undeclared Sildenafil

Boulla LLC Issues Voluntary Nationwide Recall of Boom M...

Feb 9, 2025  0

Endo USA, Inc. Issues Recall of One Lot of Clonazepam Orally Disintegrating Tablets Due to Mislabeling: Incorrect Strength on Product Carton

Endo USA, Inc. Issues Recall of One Lot of Clonazepam O...

Feb 9, 2025  0

ICU Medical Issues Nationwide Recall of Potassium Chloride Injection, 20 mEq and Potassium Chloride Injection, 10 mEq Due to Mislabeling

ICU Medical Issues Nationwide Recall of Potassium Chlor...

Feb 16, 2025  0